| Name | Title | Contact Details |
|---|
Activ Surgical is a digital surgery pioneer, envisioning a future of collaborative surgery, with surgical intelligence empowering scopes and robots to see what humans cannot see. The top surgeons in the world cannot be everywhere, but with Activ Surgical, their data and insights can be. Founded in 2017, Activ Surgical completed the world`s first autonomous robotic surgery of soft tissue and is building hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons.
Mental Health Corporation of Denver is a Denver, CO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 120 countries, Ortho`s high-quality products and services enable healthcare professionals to make better-informed treatment decisions. For the immunohematology community, Ortho`s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management, and interpretation tools to clinical laboratories around the world to help them run more efficiently, effectively and improve patient care. Ortho`s purpose is to improve and save lives with diagnostics and it does that by reimagining what`s possible. This is what has defined Ortho for more than 75 years, and it`s what drives Ortho forward.
Spectral MD is a predictive analytics company that develops proprietary optical technology and AI algorithms to help clinicians accurately make better and faster treatment decisions for burns, chronic wounds, and other pathological conditions of the skin. Spectral MD is located in the heart of Uptown Dallas, TX and London, UK.
Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.